Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Plasma carboxypeptidases as regulators of the plasminogen system.
A Redlitz, … , D L Eaton, E F Plow
A Redlitz, … , D L Eaton, E F Plow
Published November 1, 1995
Citation Information: J Clin Invest. 1995;96(5):2534-2538. https://doi.org/10.1172/JCI118315.
View: Text | PDF
Research Article Article has an altmetric score of 10

Plasma carboxypeptidases as regulators of the plasminogen system.

  • Text
  • PDF
Abstract

Authors

A Redlitz, A K Tan, D L Eaton, E F Plow

×

Total citations by year

Year: 2025 2024 2023 2021 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 Total
Citations: 2 2 1 2 1 1 2 4 3 4 4 9 5 7 6 8 14 7 12 10 12 12 12 9 6 5 7 5 1 1 174
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2009 (6)

Title and authors Publication Year
Biochemical characterization of bovine plasma thrombin-activatable fibrinolysis inhibitor (TAFI)
Z Valnickova, M Thaysen-Andersen, P Højrup, T Christensen, KW Sanggaard, T Kristensen, JJ Enghild
BMC Biochemistry 2009
A novel function of thrombin-activatable fibrinolysis inhibitor during rat liver regeneration and in growth-promoted hepatocytes in primary culture
N Okumura, T Koh, Y Hasebe, T Seki, T Ariga
The Journal of biological chemistry 2009
Carboxypeptidase U (TAFIa): a new drug target for fibrinolytic therapy?
JL Willemse, E Heylen, ME Nesheim, DF Hendriks
Journal of Thrombosis and Haemostasis 2009
Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hyperthyroidism
C Erem, O Ucuncu, M Yilmaz, M Kocak, İ Nuhoglu, HO Ersoz
Endocrine 2009
Blood coagulation and fibrinolysis in patients with Cushing’s syndrome: Increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels
C Erem, I Nuhoglu, M Yilmaz, M Kocak, A Demirel, O Ucuncu, HO Ersoz
Journal of Endocrinological Investigation 2009
Increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels in patients with primary hyperparathyroidism
C Erem, M Kocak, I Nuhoglu, M Yilmaz, O Ucuncu
European Journal of Endocrinology 2009

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 1 X users
Referenced in 3 patents
Referenced in 2 Wikipedia pages
25 readers on Mendeley
See more details